Head, Radiopharmaceutical Diagnostic Development

At RayzeBio, every day is an opportunity to ignite meaningful change. As a wholly-owned subsidiary of Bristol Myers Squibb , RayzeBio blends the nimble, pioneering spirit of an emergent biotech with the global expertise and resources of a leading innovator in oncology. Our mission is to develop transformative radiopharmaceutical therapies that offer new hope for patients living with cancer. Here, you’ll join a multidisciplinary team where your ideas are valued, your expertise is amplified, and collaboration is at the heart of everything we do. From day one, expect to make an immediate impact—on our science, on our teams, and most importantly, on patients. Learn more about RayzeBio: Position Summary The Head, Radiopharmaceutical Diagnostic Development will provide strategic and operational leadership for RayzeBio's diagnostic and companion imaging radiopharmaceutical portfolio, including PET and SPECT imaging agents used for patient selection, dosimetry, and disease monitoring across RayzeBio's radioligand therapy (RLT) programs (e.g., RYZ101, RYZ701, and the broader RYZ-series pipeline). This role owns the diagnostic development strategy end to end — from candidate nomination and CMC development through tech transfer, clinical supply, regulatory submission, and health authority approval — and partners closely with CMC, Quality, Regulatory Affairs, Clinical Development, Manufacturing, Isotope Supply Chain, and Commercial to ensure diagnostic agents are delivered on time, in compliance, and aligned to the needs of each therapeutic program. The role is global in scope: it is accountable for building and executing global development plans across the United States, Canada, the European Union, Australia/New Zealand, and the Asia-Pacific region, and for the ongoing lifecycle management of approved diagnostic products across all markets in which RayzeBio operates. Job Responsibilities Define and own the diagnostic and companion imaging development strategy across RayzeBio's